Search
for

    Sort by

    Research 301–330 of 878

    1. Treatment of Vitiligo Associated Eyebrow and Eyelash Leukotrichia - A Systematic Review of Existing Information Indian Dermatology Online Journal · 2025 · 1 citations
    2. Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata” Journal of the American Academy of Dermatology · 2025 · 1 citations
    3. Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata CPT Pharmacometrics & Systems Pharmacology · 2025 · 1 citations
    4. 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study Journal of the American Academy of Dermatology · 2023 · 1 citations
    5. 42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study Journal of the American Academy of Dermatology · 2023 · 1 citations
    6. 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss Journal of The American Academy of Dermatology · 2022 · 1 citations
    7. 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study Journal of The American Academy of Dermatology · 2021 · 1 citations
    8. 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM Journal of the American Academy of Dermatology · 2026
    9. PCR108 QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA Value in Health · 2026
    10. Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata SKIN The Journal of Cutaneous Medicine · 2025
    11. An Approach to Performing Successful Eyelash Restoration International Society of Hair Restoration Surgery · 2025
    12. 63532 Impact of Eyebrow and Eyelash Hair Loss on Health-Related Quality of Life Among Patients with Alopecia Areata: Results From a Real-World Survey in 5 European Countries Journal of the American Academy of Dermatology · 2025
    13. Bilateral Eyelash Poliosis with Raccoon Erythema and Hypopigmentation-Contact Follicular Leukoderma Dermatology Practical & Conceptual · 2025
    14. Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib. PubMed · 2025
    15. 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials Journal of the American Academy of Dermatology · 2024
    16. 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata Journal of the American Academy of Dermatology · 2024
    17. 52874 Timing of eyebrow and eyelash regrowth among subgroups of scalp responders during treatment of severe alopecia areata with baricitinib Journal of the American Academy of Dermatology · 2024
    18. Progressive Eyelash Loss and Scale of the Right Eyelid Cutis · 2024
    19. Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials JEADV Clinical Practice · 2024
    20. Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata Skin · 2023
    21. 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata Journal of The American Academy of Dermatology · 2023
    22. 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2023
    23. Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study SKIN The Journal of Cutaneous Medicine · 2023
    24. Eyelashes: Anatomical and Physiological Features, Eyelash Loss and Trichomegaly: Review Turkiye Klinikleri Journal of Ophthalmology · 2015
    25. Corneal punctate epitheliopathy secondary to trichiasis following eyelash transplantation Canadian journal of ophthalmology · 2012
    26. Long-term safety and efficacy of Latisse (bimatoprost 0.03% solution) for treatment of eyelash hypotrichosis in subjects with chemotherapy induced and idiopathic hypotrichosis Journal of The American Academy of Dermatology · 2012
    27. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata Yearbook of Dermatology and Dermatologic Surgery · 2010
    28. Ocular Side Effects of Eyelash Extension Use Among Female Students of the University of Benin, Benin City, Edo State, Nigeria Cureus · 2024 · 3 citations
    29. Photo Quiz: Persistent eyelash debris in a 10-year-old female Journal of Clinical Microbiology · 2026
    30. Correction of segmental vitiligo-associated eyelash leukotrichia using follicular unit extraction of dorsal toe hairs instead of scalp hairs Indian Journal of Dermatology Venereology and Leprology · 2026